Supreme Court Invalidates Amgen Patent Claims
Supreme Court Invalidates Amgen Patent Claims
Supreme Court Invalidates Amgen Patent Claims
News summary

Recent developments in patent law highlight significant court rulings and ongoing litigation challenges. The U.S. Supreme Court invalidated two Amgen patents, emphasizing the necessity for specific disclosures in claims of functional genus patents to ensure they are fully enabled for skilled practitioners. Meanwhile, a federal judge sanctioned Houston patent lawyer William Ramey for filing a 'frivolous' lawsuit against Volkswagen, ordering him and his client to pay $207,000 in legal fees, amid a history of similar sanctions. In Colorado, the state's high patent filing rate is celebrated, with the local Patent and Trademark Office marking a decade of outreach. Additionally, the Patent Trial and Appeal Board partially granted a motion by EP Family Corp. to amend its tabletop design patent while denying its request for a substitute claim. Lastly, a Texas court ruled several patents related to electronic object detection ineligible under patent eligibility standards, emphasizing the importance of clear and representative claims.

Story Coverage
alt
Reuters
Center
Legal Fee Tracker: Sanctions pile up for Texas patent lawyer
Bias Distribution
100% Center
Information Sources
a3544a73-dab3-486d-ae75-bd4d15f01f55
Center 100%
Coverage Details
Total News Sources
1
Left
0
Center
1
Right
0
Unrated
0
Last Updated
29 days ago
Bias Distribution
100% Center
Related News
AI Assistant
Story Coverage
alt
Reuters
Center
Legal Fee Tracker: Sanctions pile up for Texas patent lawyer
Subscribe

Stay in the Know, Subscribe to Our News

Get the latest news, exclusive insights, and curated content delivered straight to your inbox.

Related News
Recommended News